Greetings, colleagues, and here’s the latest European Alliance for Personalised Medicine (EAMP) update as we approach what we would normally call ‘Christmas’. It’s all just a...
Margaret Keenan, 90, is applauded by staff as she returns to her ward after becoming the first person in Britain to receive the Pfizer/BioNTech COVID-19 vaccine...
Britain today (2 December) became the first western country to approve a COVID-19 vaccine, jumping ahead of the United States and Europe after its regulator cleared...
EMA has received an application for conditional marketing authorization (CMA) for BNT162b2, a COVID‑19 mRNA vaccine developed by BioNTech and Pfizer. The assessment of BNT162b2 will proceed...
Watch President von der Leyen’s press statement here. “The coronavirus pandemic has affected our lives severely. Many people are ill or have lost their jobs. And right...
AstraZeneca said on Monday (23 NOvember) its COVID-19 vaccine could be around 90% effective, giving the world’s fight against the global pandemic a new weapon, cheaper...
On 17 November, the European Commission approved a fifth contract with the European pharmaceutical company CureVac, which provides for the initial purchase of 225 million doses...